{"id":"https://openalex.org/W4361960132","doi":"https://doi.org/10.1158/1078-0432.c.6522210","title":"Data from Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia\u2014Implications for Immunotherapy","display_name":"Data from Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia\u2014Implications for Immunotherapy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361960132","doi":"https://doi.org/10.1158/1078-0432.c.6522210"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6522210","doi":"https://doi.org/10.1158/1078-0432.c.6522210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6522210","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091276152","display_name":"Gerrit Weber","orcid":"https://orcid.org/0000-0001-7240-0300","observed_orcids":["https://orcid.org/0000-0001-7240-0300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerrit Weber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086097073","display_name":"Ignazio Caruana","orcid":"https://orcid.org/0000-0002-9250-0605","observed_orcids":["https://orcid.org/0000-0002-9250-0605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ignazio Caruana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015555817","display_name":"Rayne Helen Rouce","orcid":"https://orcid.org/0000-0002-0670-0599","observed_orcids":["https://orcid.org/0000-0002-0670-0599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rayne H. Rouce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049066393","display_name":"A. John Barrett","orcid":"https://orcid.org/0000-0002-6082-4437","observed_orcids":["https://orcid.org/0000-0002-6082-4437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. John Barrett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026118697","display_name":"Ulrike Gerdemann","orcid":"https://orcid.org/0000-0002-3600-0366","observed_orcids":["https://orcid.org/0000-0002-3600-0366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ulrike Gerdemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020956671","display_name":"Ann Marie Leen","orcid":"https://orcid.org/0000-0002-4470-1760","observed_orcids":["https://orcid.org/0000-0002-4470-1760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann M. Leen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010578315","display_name":"Karen R. Rabin","orcid":"https://orcid.org/0000-0002-4081-8195","observed_orcids":["https://orcid.org/0000-0002-4081-8195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen R. Rabin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006134549","display_name":"Catherine M. Bollard","orcid":"https://orcid.org/0000-0001-5140-9090","observed_orcids":["https://orcid.org/0000-0001-5140-9090"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine M. Bollard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.20720000565052032,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.11349999904632568,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.9210000038146973},{"id":"https://openalex.org/keywords/tumor-antigen-specific-t-cells","display_name":"tumor antigen-specific T cells","score":0.8650000095367432},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.8230000138282776},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.9649999737739563},{"id":"https://openalex.org/keywords/mage-a3","display_name":"MAGE-A3","score":1.0},{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":1.0},{"id":"https://openalex.org/keywords/dendritic-cell-activation","display_name":"dendritic cell activation","score":0.6729999780654907},{"id":"https://openalex.org/keywords/peptide-libraries","display_name":"peptide libraries","score":0.6129999756813049},{"id":"https://openalex.org/keywords/leukemia-relapse-prevention","display_name":"leukemia relapse prevention","score":0.7400000095367432},{"id":"https://openalex.org/keywords/high-risk-leukemia","display_name":"high-risk leukemia","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.7465215921401978},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6610983610153198},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.577140212059021},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5369880199432373},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.528928816318512},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46301859617233276},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4585132598876953},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4431282877922058},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.42686212062835693},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.41323062777519226},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3638751208782196},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3614019751548767},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35871124267578125},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3518650531768799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32983025908470154},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.15664702653884888}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6522210","doi":"https://doi.org/10.1158/1078-0432.c.6522210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6522210","doi":"https://doi.org/10.1158/1078-0432.c.6522210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2130309988","https://openalex.org/W2968969925","https://openalex.org/W2914219564","https://openalex.org/W2980250177","https://openalex.org/W2575942073","https://openalex.org/W2098690052","https://openalex.org/W2998088936","https://openalex.org/W2034618730","https://openalex.org/W2047788611","https://openalex.org/W2015745605"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Although":[2],"modern":[3],"cure":[4],"rates":[5],"for":[6],"childhood":[7],"acute":[8],"lymphoblastic":[9],"leukemia":[10,199],"(ALL)":[11],"exceed":[12],"80%,":[13],"the":[14,57,71,80,91,169,211,228],"outlook":[15],"remains":[16],"poor":[17],"in":[18,162,183,201],"patients":[19,75,96,167,231],"with":[20,48,60,76,97,119,124,215,232],"high-risk":[21,74,104,233],"disease":[22],"and":[23,41,63,105,132,153,172,187,203,226],"those":[24],"who":[25],"relapse,":[26],"especially":[27],"when":[28],"allogeneic":[29],"hematopoietic":[30],"stem":[31],"cell":[32],"transplantation":[33],"is":[34],"not":[35],"feasible.":[36],"Strategies":[37],"to":[38,69,174,223],"improve":[39,70,227],"outcome":[40,72],"prevent":[42,224],"relapse":[43,225],"are":[44],"therefore":[45,64],"required.":[46],"Immunotherapy":[47],"antigen-specific":[49,85,220],"T":[50,86,221],"cells":[51,87,116,122,222],"can":[52],"have":[53],"antileukemic":[54],"activity":[55],"without":[56],"toxicities":[58],"seen":[59],"intensive":[61],"chemotherapy,":[62],"represents":[65],"an":[66],"attractive":[67],"strategy":[68],"of":[73,82,94,128,155,166,197,213,230],"ALL.":[77,234],"We":[78],"explored":[79],"feasibility":[81],"generating":[83],"tumor":[84,219],"ex":[88],"vivo":[89],"from":[90,146],"peripheral":[92],"blood":[93,114],"50":[95],"ALL":[98,138],"[26":[99],"National":[100],"Cancer":[101,236],"Institute":[102],"(NCI)":[103],"24":[106],"standard-risk]":[107],"receiving":[108],"maintenance":[109],"therapy.":[110],"Experimental":[111],"Design:":[112],"Peripheral":[113],"mononuclear":[115],"were":[117,143,193],"stimulated":[118],"autologous":[120,198,218],"dendritic":[121],"pulsed":[123],"complete":[125],"peptide":[126],"libraries":[127],"WT1,":[129],"Survivin,":[130],"MAGE-A3,":[131],"PRAME,":[133],"antigens":[134],"frequently":[135],"expressed":[136],"on":[137],"blasts.":[139],"Results:":[140],"T-cell":[141],"lines":[142],"successfully":[144],"expanded":[145],"all":[147],"patients,":[148],"despite":[149],"low":[150],"lymphocyte":[151],"counts":[152],"irrespective":[154],"NCI":[156],"risk":[157],"group.":[158],"Antigen-specificity":[159],"was":[160],"observed":[161,194],"more":[163,175],"than":[164,176],"50%":[165],"after":[168,178],"initial":[170],"stimulation":[171],"increased":[173],"90%":[177],"three":[179],"stimulations":[180],"as":[181],"assessed":[182],"IFN-\u03b3-enzyme-linked":[184],"immunospot":[185],"(ELISpot)":[186],"51Cr-release":[188],"assays.":[189],"Moreover,":[190],"tumor-specific":[191],"responses":[192],"by":[195],"reduction":[196],"blasts":[200],"short-":[202],"long-term":[204],"coculture":[205],"experiments.":[206],"Conclusion:":[207],"This":[208],"study":[209],"supports":[210],"use":[212],"immunotherapy":[214],"adoptively":[216],"transferred":[217],"prognosis":[229],"Clin":[235],"Res;":[237],"19(18);":[238],"5079\u201391.":[239],"\u00a92013":[240],"AACR.":[241]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}